CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 µM). CHD1Li 6.11 is an orally active antitumour agent that significantly reduces the tumour volume of CRC xenografts generated from isolated quasi-mesenchymal cells (M phenotype) with enhanced tumourigenic properties. These cells have enhanced tumourigenic properties.
Molecular Weight:
472.4
Purity:
98.03%
CAS Number:
[2716890-91-2]
Formula:
C21H22BrN5OS
Target:
Others|||DNA/RNA Synthesis
T63049
* VAT and and shipping costs not included. Errors and price changes excepted